SCHEMBL31228389

SCHEMBL31228389

Cc1ccc(S(=O)(=O)OC[C@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2C(=O)N(C)[C@H](C(=O)O)C(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 7/20 0.40
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
P2RX7 Q99572 2/20 0.36
ADAM17 P78536 1/20 0.35
TACR1 P25103 1/20 0.35
STAT3 P40763 1/20 0.34
GPR119 Q8TDV5 3/20 0.34
MC4R P32245 1/20 0.33
LIMK2 P53671 1/20 0.33
MMP1 P03956 3/20 0.33
MMP3 P08254 3/20 0.33
MMP7 P09237 3/20 0.33
MMP9 P14780 3/20 0.33
MMP8 P22894 3/20 0.33
MMP2 P08253 2/20 0.33
JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228513 0.89 P2RX7 (0.44) MEN1KMT2AP2RX7ADAM17TACR1
SCHEMBL31228427 0.85 MMP13 (0.37) MMP13MEN1KMT2AP2RX7TACR1
SCHEMBL31228306 0.82 MMP13 (0.40) MMP13MEN1KMT2AP2RX7STAT3
SCHEMBL31153630 0.82 MMP13 (0.40) MMP13MEN1KMT2AP2RX7STAT3
SCHEMBL31228300 0.82 MMP13 (0.40) MMP13MEN1KMT2AP2RX7STAT3
SCHEMBL31282646 0.81 KMT2A (0.47) MMP13MEN1KMT2AP2RX7GPR119
SCHEMBL31228239 0.81 MMP13 (0.39) MMP13MEN1KMT2AP2RX7GPR119
SCHEMBL27228981 0.78 KMT2A (0.44) MMP13MEN1KMT2AP2RX7GPR119
SCHEMBL26907202 0.78 KMT2A (0.44) MMP13MEN1KMT2AP2RX7GPR119
SCHEMBL31228367 0.75 MMP13 (0.40) MMP13MEN1KMT2AP2RX7STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688789-A1 MACROCYCLIC RAS INHIBITORS Revolution Medicines, Inc. (US) 2026-02-11 EP disclosed
WO-2024211663-A9 MACROCYCLIC RAS INHIBITORS Revolution Medicines, Inc. (US) 2025-01-30 WO disclosed
WO-2024211663-A1 CONDENSED MACROCYCLIC COMPOUNDS AS RAS INHIBITORS Revolution Medicines, Inc. (US) 2024-10-10 WO disclosed